Both in Pharmaceuticals
Braveheart Bio vs Xeris Biopharma Holdings
Over the past year BRVE returned −21.2% and XERS returned +42.3%; their daily moves had a correlation of 0.07.
BRVE −21.2% XERS +42.3%Growth of $1, one year, split-adjusted
| Metric | BRVE | XERS |
|---|---|---|
| Price | $21.00 | $10.61 |
| Market cap | $1.89B | $1.93B |
| Today | −0.92% | −1.35% |
| 1 month | −1.9% | +14.6% |
| 6 months | — | +68.9% |
| Year to date | — | +35.1% |
| 1 year | — | +10.2% |
| Revenue growth (YoY) | — | +28.7% |
| Gross margin | — | 86.4% |
| Net margin | — | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.8× |
| Net cash | — | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 53.1% |
| Short % of float | 10.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).